Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-18

FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approves a supplemental application for Strides Pharma Science Limited's methimazole, updating the already approved product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)